DigestRedComo funciona
Red
/
Empresas
Ca
No verificado

Capsida Biotherapeutics

Sobre qué escribimos

BiotecnologíaHigiene alimentariaIndustriaMedicina - VariosSalud

5 Comunicados de prensa

Ver todos los comunicados de prensa
11/06/2025
Higiene alimentaria
Salud
Biotecnología
Farmacéutica
Medicina - Varios
Industria
Capsida Receives FDA IND Clearance for Its IV-Administered Gene Therapy for Parkinson’s Disease Associated With GBA Mutations
Fuente
Capsida Biotherapeutics
Editor
Business Wire
1.00
0
29/05/2025
Salud
Higiene alimentaria
Biotecnología
Medicina - Varios
Farmacéutica
Industria
Capsida Receives FDA Fast Track Designation for Its Potential First-in-Class IV-Administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
Fuente
Capsida Biotherapeutics
Editor
Business Wire
1.00
0
14/05/2025
Industria
Salud
Biotecnología
Medicina - Varios
Ciencia
Farmacéutica
Capsida Presents New GLP Toxicology Data Supporting Recent FDA IND Clearance of Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
Fuente
Capsida Biotherapeutics
Editor
Business Wire
1.00
0
12/05/2025
Biotecnología
Higiene alimentaria
Salud
Medicina - Varios
Capsida Receives FDA IND Clearance for Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
Fuente
Capsida Biotherapeutics
Editor
Business Wire
1.00
0
28/04/2025
Web y redes sociales
Eventos
Salud
Biotecnología
Ciencia
Sanidad
Capsida to Present Progress Updates at the ASGCT Annual Meeting, Including NHP GLP Toxicology Study Results for its Potential First-in-Class STXBP1 Developmental and Epileptic Encephalopathy Program (CAP-002 STXBP1-DEE)
Fuente
Capsida Biotherapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0